BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8633249)

  • 1. CPT-11: an original spectrum of clinical activity.
    Rothenberg ML
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):21-6. PubMed ID: 8633249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPT-11 in the treatment of colorectal cancer: clinical efficacy and safety profile.
    Rougier P; Bugat R
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):34-41. PubMed ID: 8633252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase I inhibitors in the treatment of colorectal cancer.
    Rothenberg ML; Blanke CD
    Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical activity spectrum of irinotecan].
    Cottu PH; Extra JM; Lerebours F; Espie M; Marty M
    Bull Cancer; 1998 Dec; Spec No():21-5. PubMed ID: 9932080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CPT-11 (irinotecan) in the treatment of colorectal cancer.
    Armand JP; Ducreux M; Mahjoubi M; Abigerges D; Bugat R; Chabot G; Herait P; de Forni M; Rougier P
    Eur J Cancer; 1995; 31A(7-8):1283-7. PubMed ID: 7577037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.
    Cunningham D
    Eur J Cancer; 1996; 32A Suppl 3():S1-8. PubMed ID: 8943658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of CPT-11 (irinotecan) as a single agent in metastatic colorectal cancer.
    Shimada Y; Rougier P; Pitot H
    Eur J Cancer; 1996; 32A Suppl 3():S13-7. PubMed ID: 8943660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPT-11 in gastrointestinal cancer.
    Bleiberg H
    Eur J Cancer; 1999 Mar; 35(3):371-9. PubMed ID: 10448285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of topoisomerase I inhibitors in small-cell lung cancer.
    Fukuoka M
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and clinical trials of topoisomerase inhibitors.
    Saijo N
    Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPT-11: the European clinical development.
    Terret C; Couteau C; Armand JP
    J Infus Chemother; 1996; 6(3):152-7. PubMed ID: 9229329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan therapy for small-cell lung cancer.
    Sandler A
    Oncology (Williston Park); 2002 Apr; 16(4):419-25, 428, 433; discussion 433-4, 437-8. PubMed ID: 12017533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of chemotherapy for advanced colorectal cancer: new opportunities.
    Bleiberg H
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):42-50. PubMed ID: 8633253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials.
    Saijo N; Nishio K; Kubota N; Kanzawa F; Shinkai T; Karato A; Sasaki Y; Eguchi K; Tamura T; Ohe Y
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S112-7. PubMed ID: 8070019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of irinotecan in colorectal cancer.
    Saltz LB
    Curr Oncol Rep; 1999; 1(2):155-60. PubMed ID: 11122813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irinotecan and radiation in combined-modality therapy for solid tumors.
    Choy H; MacRae R
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):22-8. PubMed ID: 11497228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere.
    Sato T; Hatate K; Ikeda A; Yamanashi T; Ozawa H; Onosato W; Nakamura T; Ihara A; Watanabe M
    Expert Opin Pharmacother; 2008 May; 9(7):1223-8. PubMed ID: 18422478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPT-11. The European experience.
    Armand JP; Terret C; Couteau C; Rixe O
    Ann N Y Acad Sci; 1996 Dec; 803():282-91. PubMed ID: 8993522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro sensitivity of fresh ovarian carcinoma specimens to CPT-11 (irinotecan).
    O'meara AT; Sevin BU
    Gynecol Oncol; 1999 Feb; 72(2):143-7. PubMed ID: 10021292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan: toward clinical end points in drug development.
    Pazdur R
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):13-21. PubMed ID: 9726086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.